UROPLASTY INC 4
4 · UROPLASTY INC · Filed Apr 2, 2015
Insider Transaction Report
Form 4
WEHRWEIN SVEN
Director
Transactions
- Disposition to Issuer
Stock Option (right to buy)
2015-03-31−7,025→ 0 totalExercise: $3.76Exp: 2019-09-12→ Common Stock (7,025 underlying) - Disposition to Issuer
Stock Option (right to buy)
2015-03-31−6,175→ 0 totalExercise: $4.16Exp: 2017-09-13→ Common Stock (6,175 underlying) - Disposition to Issuer
Stock Option (right to buy)
2015-03-31−8,625→ 0 totalExercise: $3.46Exp: 2020-09-11→ Common Stock (8,625 underlying) - Disposition to Issuer
Common Stock
2015-03-31−43,625→ 0 total - Disposition to Issuer
Stock Option (right to buy)
2015-03-31−5,475→ 0 totalExercise: $4.83Exp: 2018-09-13→ Common Stock (5,475 underlying)
Footnotes (5)
- [F1]Disposed of pursuant to merger agreement between issuer and Cogentix Medical, Inc., formerly Vision-Sciences, Inc. ("Cogentix"), in exchange for 31,698 shares of Cogentix common stock on the effective date of the merger.
- [F2]This option is fully vested, was assumed by Cogentix in the merger and replaced with an option to purchase 4,486 shares of Cogentix stock for $5.73 per share.
- [F3]This option is fully vested, was assumed by Cogentix in the merger and replaced with an option to purchase 3,978 shares of Cogentix stock for $6.65 per share.
- [F4]This option is fully vested, was assumed by Cogentix in the merger and replaced with an option to purchase 5,104 shares of Cogentix stock for $5.18 per share.
- [F5]This option is fully vested, was assumed by Cogentix in the merger and replaced with an option to purchase 6,267 shares of Cogentix stock for $4.77 per share.